<!doctype html><html lang="zh-hans"><head><meta charset="utf-8"><meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no"><title>抗衰老：最新技术 Anti-Aging: State of the Art</title><link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css" integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous"><link rel="stylesheet" href="/img/css.css?random="><link data-rh="true" rel="icon" href="/img/favicon.ico"/><script data-ad-client="ca-pub-6067137220025946" async src="https://pagead2.googlesyndication.com/pagead/js/adsbygoogle.js"></script><script type="text/javascript" src="https://platform-api.sharethis.com/js/sharethis.js#property=5effb96910009800120b8d4d&product=inline-share-buttons" async="async"></script>
<script>var _hmt = _hmt || [];(function() {var hm = document.createElement("script");hm.src = "https://hm.baidu.com/hm.js?03c1a0f31299b4a2fbb83c34d6beaac9";var s = document.getElementsByTagName("script")[0]; s.parentNode.insertBefore(hm, s);})();</script></head><body><div id="my_header"><div class="container"><nav class="navbar navbar-expand-lg"><a class="navbar-brand" href="/"><img alt="diglog" src="/img/logo.v1.gif" class="rounded-sm"></a><button class="navbar-toggler" type="button" data-toggle="collapse" data-target="#navbarNavAltMarkup" aria-controls="navbarNavAltMarkup" aria-expanded="false" aria-label="Toggle navigation"><span class="navbar-toggler-icon"></span></button><div class="collapse navbar-collapse" id="navbarNavAltMarkup"><div class="navbar-nav"></div></div></nav></div></div><div class="container"><div id="my_content"><h1 class="page_narrow">Anti-Aging: State of the Art<br/>抗衰老：最新技术 </h1><div class="row"><div class="col-lg-12 col-12"><div class="my_story_list_item shadow p-3 mb-5 bg-white rounded"><div class="story_page_pub_time page_narrow">2021-01-02 08:35:44</div><div class="story_img_container"><a href="http://img2.diglog.com/img/2021/1/8c7c206664637f318f5a7ea672a9bad9.png"><img src="http://img2.diglog.com/img/2021/1/8c7c206664637f318f5a7ea672a9bad9.png" class="img-fluid my_story_img" onerror="this.style.display='none'"></a></div><div class="page_narrow text-break page_content"><p>Aging is a problem that ought to be solved, and most Less Wrongers recognize this. However, few members of the community seem to be aware of the current state of the anti-aging field, and how close we are to developing effective anti-aging therapies. As a result, there is a much greater (and in my opinion, irrational) overemphasis on the  Plan B of cryonics for life extension, rather than  Plan A of solving aging. Both are important, but the latter is under-emphasised despite being a potentially more feasible strategy for life extension given the potentially  high probability that cryonics will not work.</p><p>老龄化是一个应该解决的问题，大多数少冤家都承认这一点。但是，社区中几乎没有成员知道抗衰老领域的现状，以及我们距离开发有效的抗衰老疗法有多近。结果，对于延长寿命的冷冻机计划B的重视程度过高（在我看来，这是非理性的），而不是解决衰老的计划A。两者都很重要，但是考虑到冷冻装置可能无法工作的可能性，尽管后者是延长寿命的一种更可行的策略，但后者却未得到充分重视。</p><p> Today, there are over   130 longevity biotechnology companies and over   50 anti-aging drugs in clinical trials in humans. The evidence is promising that in the next 5-10 years, we will start seeing robust evidence that aging can be therapeutically slowed or reversed in humans. Whether we live to see anti-aging therapies to keep us alive indefinitely (i.e. whether we make it to   longevity escape velocity) depends on how much traction and funding the field gets in coming decades.</p><p> 如今，已有超过130家长寿生物技术公司和50多种抗衰老药物在人体中进行临床试验。有证据表明，在未来的5-10年中，我们将开始看到有力的证据表明，衰老可以通过治疗性方式减缓或逆转人类的生命。我们是否会看到抗衰老疗法无限期地维持我们的生命（即我们是否达到长寿逃生速度）取决于该领域在未来几十年中将获得多少牵引力和资金。</p><p> In this post, I summarise the state of the art of the anti-aging field (also known as  longevity biotechnology, rejuvenation biotechnology, translational biogerontology or  geroscience). If you feel you already possess the necessary background on aging, feel free to skip to  Part V.</p><p> 在这篇文章中，我总结了抗衰老领域的最新技术（也称为长寿生物技术，复兴生物技术，转化生物老年医学或老年科学）。如果您认为自己已经具备必要的衰老背景，请随时跳至第五部分。</p><p>   Aging is the biggest killer worldwide, and also the   largest source of morbidity. Aging kills   100,000 people per day; more than twice the sum of all other causes of death. This equates to 37 million people - a population the size of Canada - dying per day of aging. In developed countries, 9 out of 10 deaths are due to aging.</p><p>   衰老是全球最大的杀手，也是最大的发病源。老龄化每天杀死10万人；是所有其他死亡原因之和的两倍以上。这相当于每天有3,700万人（每天人口死亡）（相当于加拿大的人口）。在发达国家，十分之九的死亡是由于老龄化。</p><p> Aging also accounts for more than   30% of all disability-adjusted life years lost (DALYs); more than any other single cause. Deaths due to aging are not usually quick and painless, but preceded by 10-15 years of chronic illnesses such as cancer, type 2 diabetes and Alzheimer’s disease. Quality of life typically deteriorates in older age, and the   highest rates of depression worldwide are among the elderly.</p><p> 衰老还占失去的所有残疾调整生命年（DALY）的30％以上；比其他任何单一原因都重要。由于衰老而导致的死亡通常不是很快而无痛的，而是在10-15年的慢性疾病（如癌症，2型糖尿病和阿尔茨海默氏病）之前死亡。生活质量通常会随着年龄的增长而恶化，并且全世界抑郁症的患病率最高的是老年人。</p><p> To give a relevant example of the effects of aging, consider that aging is primarily responsible for almost all COVID-19 deaths. This is observable in the strong association of COVID-19 mortality with age (below, middle panel):</p><p> 为了说明衰老的影响，请考虑衰老是几乎所有COVID-19死亡的主要原因。在COVID-19死亡率与年龄的强烈关联中可以观察到这一点（下图，中图）：</p><p>  The death rate from COVID-19   increases exponentially with age (above, middle). This is not a coincidence - it is because biological aging   weakens the immune system and results in a much higher chance of death from COVID-19. On a side note, waning immunity with age also   increases cancer risk, as another example of how aging is associated with chronic illness.</p><p>  COVID-19的死亡率随年龄（上，中）呈指数增长。这不是巧合-这是因为生物衰老削弱了免疫系统，并导致死于COVID-19的可能性更高。附带说明，随着年龄的增长免疫力的下降也增加了患癌症的风险，这是衰老与慢性疾病如何相关的另一个例子。 </p><p> The mortality rate doubling time for COVID-19 is   close to the all-cause mortality rate doubling time, suggesting that people who  die of COVID-19 are really  dying of aging. Without aging, COVID-19 would not be a global pandemic, since the death rate in individuals   below 30 years old is extremely low.</p><p>COVID-19的死亡率翻倍时间接近全因死亡率的翻倍时间，这表明死于COVID-19的人真的快死了。如果不衰老，COVID-19不会成为全球大流行病，因为30岁以下的人的死亡率极低。</p><p>   For those who have broken free of the   pro-aging trance and recognise aging as a problem, there is the further challenge of imagining a world without aging. The prominent ‘black mirror’ portrayals of immortality as a curse or hubristic may distort our model of what a world with anti-aging actually looks like.</p><p>   对于那些摆脱了衰老tr，认识到衰老是一个问题的人来说，要想像一个没有衰老的世界还面临着进一步的挑战。著名的“黑镜”描绘了不朽为诅咒或暴行，可能会扭曲我们关于抗衰老世界的模样。</p><p> The &#39;white mirror&#39; of aging is a world in which biological age is halted at 20-30 years, and people maintain optimal health for a much longer or indefinite period of time. Although people will still age chronologically (exist over time) they will not undergo physical and cognitive decline associated with biological aging. At chronological ages of 70s, 80s, even 200s, they would maintain the physical appearance and much lower disease risk of a 20-30-year-old.</p><p> 白色镜子衰老是一个世界，在这个世界中，生物年龄被停止在20到30岁之间，人们可以维持更长或更长时间的最佳健康状态。尽管人们仍会按时间顺序（随着时间的推移而存在）衰老，但他们不会经历与生物衰老相关的身体和认知衰退。在70年代，80年代甚至200年代的年龄，他们将保持身体外观，并降低20至30岁的患病风险。</p><p> This may sound like science fiction but is a phenomenon exhibited by other species such as hydras, naked mole rats, tortoises, whales, and sharks - the latter of which can live up to   400 years old. While these species do eventually die, their risk of disease does not change over time - a phenomenon known as &#39;  negligible senescence&#39; - and these species do not age. In contrast, as humans, we experience an   exponentially increasing risk of death over time due to aging , a phenomenon known as   Gompertz law. Yet this law does is not an ingrained law of biology or the result of entropy, as it does not apply to other species, and the goal of anti-aging is to attain negligible senescence in humans.</p><p> 这听起来像科幻小说，但是其他物种所表现出的现象，例如九头蛇，裸mole鼠，乌龟，鲸鱼和鲨鱼-后者可以活到400岁。虽然这些物种最终会死亡，但其疾病风险不会随时间改变-这种现象称为“衰老可以忽略不计-这些物种不会老化。相比之下，作为人类，随着年龄的增长，我们经历死亡的风险呈指数级增长，这种现象被称为Gompertz定律。然而，该定律不是生物学的根深蒂固的定律，也不是熵的结果，因为它不适用于其他物种，而抗衰老的目的是在人类中获得可忽略的衰老。</p><p>   Transitioning to an ageless population would come with several social implications that will need to be considered such as overpopulation, climate impact, immortal dictators and distributional justice. I’ll save a deeper discussion of these for a future post, but you can read responses to these objections   here and by   Aubrey de Grey,   David Wood and others.</p><p>   过渡到无龄人口将带来一些社会影响，例如人口过剩，气候影响，不朽独裁者和分配正义等。我将在以后的文章中对这些问题进行更深入的讨论，但是您可以在此处以及Aubrey de Grey，David Wood和其他人阅读对这些异议的回复。</p><p>   Aging is essentially damage that accumulates over time, which   exponentially increases the risk of the diseases that kill most people (shown below):</p><p>   老化本质上是随时间累积的伤害，成倍增加了致死大多数人的疾病的风险（如下所示）：</p><p>  This &#39;damage&#39; associated with aging comes in essentially 9 forms, known as the   hallmarks of aging:</p><p>  这种损坏与衰老相关的本质上有9种形式，称为衰老的标志： </p><p>  The hallmarks of aging are shown in the context of the cellular and extracellular microenvironment are depicted below:</p><p>在细胞和细胞外微环境的背景下显示了衰老的标志，如下所示：</p><p>  These forms of cellular damage drive the increased risk of disease, frailty, cognitive decline as well as observable signs of aging such as grey hair, frailty and wrinkles. I&#39;m going to save a deeper discussion of the hallmarks and their link to chronic diseases for a future post, but for excellent reviews on this topic I recommend   this,   this and   this.</p><p>  这些形式的细胞损伤导致患病，脆弱，认知能力下降以及可观察到的衰老迹象（如白发，脆弱和皱纹）的风险增加。我将在以后的文章中保留对标记及其与慢性病的联系的更深入的讨论，但是对于有关此主题的出色评论，我建议使用此，本和本。</p><p>   The &#39;damage&#39; (hallmarks of aging) occurs as a by-product of normal metabolism - the biochemical reactions that keep us alive. More and more damage accumulates and eventually leads to  pathology, i.e. disease. When we talk about  anti-aging we are talking about   fixing the damage using an engineering approach before it accumulates to a dangerous level at which diseases emerge.</p><p>   损害（衰老的标志）是正常新陈代谢的副产品-维持我们生命的生化反应。越来越多的损伤累积并最终导致病理学即疾病。当我们谈论抗衰老时，我们所谈论的是使用工程方法来修复损害，直到损害累积到危险水平，使疾病出现。</p><p>  This basic model of aging can be understood as similar to the damage accumulated by a car. In its normal use, a car accrues damage that increases the likelihood that it will break down. Anti-aging is equivalent to maintaining a car, to prevent it from breaking down in the first place.</p><p>  这种老化的基本模型可以理解为类似于汽车累积的损坏。在正常使用中，汽车产生的损坏会增加其损坏的可能性。抗衰老相当于维护汽车，从一开始就防止汽车发生故障。</p><p>   Anti-aging is more feasible for extending healthy lifespan rather than solving the individual diseases of aging due to   Taueber’s paradox and the highly comorbid nature of age-related diseases. Even if a person survives one age-related disease such as cancer, another (e.g. diabetes, cardiovascular disease) will kill them if aging is not solved. This accounts for the much smaller increase in healthy lifespan associated with curing the diseases of aging, such as cancer (2-3 years), versus slowing aging itself (30+ years):</p><p>   抗衰老更适合延长健康的寿命，而不是解决因Taueber悖论和与年龄有关的疾病的高度合并症而引起的个别衰老疾病。即使一个人幸存了一种与年龄相关的疾病，例如癌症，如果不能解决衰老，另一种疾病（例如糖尿病，心血管疾病）也会杀死他们。与延缓衰老本身（超过30年）相比，与治愈衰老等疾病（如癌症）相关的健康寿命增长幅度要小得多（2-3年）：</p><p>   The difference between anti-aging and current medicine is the former prevents illness by targeting the hallmarks of aging, whereas the latter intervenes once a disease has emerged. If we compare current medical interventions associated with geriatrics with anti-aging - the former extends  unhealthy lifespan, whereas only the latter extends  healthy lifespan.</p><p>   抗衰老与目前的药物之间的区别在于，前者通过针对衰老的特征来预防疾病，而后者则在疾病出现后进行干预。如果我们将当前与老年病相关的医学干预措施与抗衰老进行比较，前者可以延长不健康的寿命，而只有后者可以延长健康的寿命。</p><p>  Therefore, there is strong reason to think that anti-aging will be more successful in extending healthy lifespan than the   ‘sick-care’ approach of current medicine.</p><p>  因此，有充分的理由认为，抗衰老将比现有药物的“病态护理”方法在延长健康寿命方面更加成功。 </p><p>   In the lab, we have demonstrated that various anti-aging approaches can extend healthy lifespan in many model organisms including   yeast, worms, fish, flies, mice and rats. Life extension of model organisms using anti-aging approaches ranges from   30% to 1000%:</p><p>在实验室中，我们已经证明了各种抗衰老方法可以延长许多模型生物的健康寿命，包括酵母，蠕虫，鱼，蝇，小鼠和大鼠。使用抗衰老方法可使模型生物的寿命延长30％至1000％：</p><p>  These results demonstrate that aging is plastic, and not a fixed process. In mice, some of the most effective approaches to life extension are summarised below:</p><p>  这些结果表明老化是可塑性的，而不是固定过程。在小鼠中，一些最有效的延长寿命的方法总结如下：</p><p>  The plasticity of aging in model organisms that share similar metabolic physiology to us provides us good proof-of-principle that aging can be slowed in humans. It remains to be seen how much life extension is possible, and improved   biomarkers of aging will be needed to accurately measure the effectiveness of new therapies in a reasonable time-frame.</p><p>  与我们有着相似代谢生理的模型生物中衰老的可塑性为我们提供了可以延缓人类衰老的良好原理证明。仍有可能延长寿命，还需要改善衰老的生物标志物，以在合理的时间范围内准确衡量新疗法的有效性。</p><p>   The past 5 years of research have demonstrated several anti-aging strategies as particularly promising. The diagram below, taken from a   2019 review by researchers at Stanford University summarises four of the most promising approaches to slow or reverse aging in humans, based on studies in mice:</p><p>   过去5年的研究表明，几种抗衰老策略特别有前途。下图取自斯坦福大学研究人员2019年的评论，该图基于对小鼠的研究总结了四种最有希望的减缓或逆转人类衰老的方法：</p><p>  The above diagram may be quite technical for non-biomedical scientists, so I&#39;ll briefly describe the approaches individually in simpler terms. Note that each of these strategies helps to reverse one or more of the   hallmarks of aging.</p><p>  上图对于非生物医学科学家来说可能是相当技术性的，因此我将以较简单的术语分别简要介绍这些方法。请注意，这些策略中的每一种都有助于逆转衰老的一个或多个特征。</p><p>   Parabiosis (heterochronic parabiosis) is putting young blood into old mice, to make the old mice biologically younger. This is achieved in the lab by connecting the circulatory systems of young mice and old mice. Certain factors in the blood help to   rejuvenate muscle, heart brain and liver tissues in old mice and restore their biological function.</p><p>   共生（异时共生）正在将年幼的血液注入老年小鼠，从而使老年小鼠在生物学上更年轻。在实验室中，这是通过连接年轻小鼠和老年小鼠的循环系统来实现的。血液中的某些因素有助于使老年小鼠的肌肉，心脏，大脑和肝脏组织恢复活力，并恢复其生物学功能。</p><p> Equivalent procedures that modify the compounds within blood in humans such as apheresis (blood filtering) could be used to slow aging in humans and thereby prevent or slow the progression of many types of age-related diseases including   Alzheimer&#39;s disease.</p><p> 可以使用等价的程序来修饰人类血液中的化合物，例如单采血液分离术（血液过滤），以减缓人类的衰老，从而预防或减慢包括阿尔茨海默氏病在内的许多类型的与年龄有关的疾病的进程。 </p><p> Recently, a group of Russian biohackers recently performed   the first plasma dilution experiments in humans. In a research context, the safety and effectiveness of apheresis is being tested in a   clinical trial in humans by the company Alkahest.</p><p>最近，一群俄罗斯生物黑客最近在人体中进行了首次血浆稀释实验。在研究背景下，Alkahest公司正在一项针对人类的临床试验中对血液分离的安全性和有效性进行了测试。</p><p> Hallmarks reversed: parabiosis reverses age-related decline by targeting several   hallmarks of aging including stem cell exhaustion, cellular senescence and altered intercellular communication (inflammation).</p><p> 逆转的特征：共生体通过针对衰老的几个特征来逆转与年龄相关的衰落，包括干细胞衰竭，细胞衰老和改变的细胞间通讯（炎症）。</p><p>   Dietary restriction has been shown to   extend healthy lifespan across several species. Drugs that mimic the metabolic effects of dietary restriction also have beneficial effects on lifespan. Nutrient-sensing biochemical pathways (  such as IGF-1, mTOR and AMPK) play a key role in these effects. Metformin is a drug that is   FDA-approved for diabetes that   extends healthy lifespan in mice by inhibiting mTOR and activating autophagy. Metformin is currently being tested in a   large clinical trial in humans to test its anti-aging properties.</p><p>   饮食限制已被证明可以延长多种物种的健康寿命。模仿饮食限制的代谢作用的药物也对寿命有有益作用。营养敏感的生化途径（例如IGF-1，mTOR和AMPK）在这些作用中起关键作用。二甲双胍是经FDA批准用于糖尿病的药物，可通过抑制mTOR和激活自噬来延长小鼠的健康寿命。二甲双胍目前正在一项针对人类的大型临床试验中进行测试，以测试其抗衰老特性。</p><p>  Hallmarks of aging targeted: The widespread mechanisms of action of metformin help to improve all of the 9 hallmarks of aging, shown below. I&#39;ll save the details for those interested, who can read a more thorough review   here.</p><p>  靶向的衰老标志：二甲双胍的广泛作用机制有助于改善所有9个衰老标志，如下所示。我将为感兴趣的人保存详细信息，他们可以在此处阅读更详尽的评论。</p><p>  Another promising drug that manipulates metabolism is rapamycin (also known as siromilus), an   FDA-approved immunosuppressant that extends healthy lifespan in mice and similarly   acts to inhibit mTOR. Rapamycin is currently in a   clinical trial in humans to test its anti-aging properties.</p><p>  操纵新陈代谢的另一种有前途的药物是雷帕霉素（也称为西罗米卢），这是一种FDA批准的免疫抑制剂，可延长小鼠的健康寿命，并同样具有抑制mTOR的作用。雷帕霉素目前正在人体中进行临床试验，以测试其抗衰老特性。</p><p>   Senescent cells are a kind of &#39;zombie&#39;-like cell that accumulate with age. They are death-resistant cells that secrete proinflammatory factors associated with a   range of age-related diseases (below, right):</p><p>   衰老细胞是一种随年龄而积累的“僵尸”样细胞。它们是抗死亡细胞，可分泌与多种与年龄有关的疾病相关的促炎因子（下图，右图）：</p><p>  There are   various strategies being explored to kill or reprogram senescent cells (above, left), including senolytics. Senolytics are drugs that kill senescent cells to improve physical function and healthy lifespan. When administered to older mice, senolytics have been shown to   reverse many aspects of aging such as cataracts, and arthritis (below):</p><p>  人们正在探索杀死或重新编程衰老细胞（上图，左图）的各种策略，包括senolytics。 Senolytics是杀死衰老细胞以改善身体功能和健康寿命的药物。当对老年小鼠给药时，senolytics已被证明可以逆转衰老的许多方面，例如白内障和关节炎（下）： </p><p>  Killing senescent cells with senolytics extends the median healthy lifespan by up to   27% in mice (below). Several senolytics, such as the combination of   dasatinib and quercetin, and   fisetin are in clinical trials in humans today.</p><p>用senolytics杀死衰老细胞可以延长小鼠的健康寿命中值，最高可达27％（下图）。如今，几种senolytics（例如达沙替尼和槲皮素的组合以及非瑟定）正在人体中进行临床试验。</p><p>  Hallmarks of aging reversed: senolytics decelerate cellular senescence, improve epigenetic markers and restore intercellular communication (by reducing inflammation associated with senescent cells) to extend healthy lifespan.</p><p>  衰老的特征逆转：senolytics可以降低细胞衰老，改善表观遗传学标记并恢复细胞间通讯（通过减少与衰老细胞相关的炎症），从而延长健康寿命。</p><p>   Cellular reprogramming is the conversion of terminally differentiated cells (old cells) into induced pluripotent stem cells (IPSCs) (‘young’ cells). Cells can be re-programmed to a youthful state using a cocktail of 4 factors known as Yamanaka factors, a finding for which a   Nobel prize was awarded in 2012.</p><p>   细胞重编程是将终末分化细胞（旧细胞）转换为诱导性多能干细胞（IPSC）（“年轻”细胞）。可以使用称为Yamanaka因子的4种因子将细胞重新编程至年轻状态，这一发现在2012年获得了诺贝尔奖。</p><p> Induced pluripotent stem cells (IPSCs) have essentially unlimited regenerative capacity and carry the promise for tissue replacement to counter age-related decline. Partial reprogramming in mice has shown promising results in alleviating age-related symptoms   without increasing the risk of cancer.</p><p> 诱导型多能干细胞（IPSC）基本上具有无限的再生能力，并有望用于组织替代以对抗与年龄有关的衰老。在小鼠中进行部分重编程已显示出在减轻与年龄有关的症状而不增加患癌风险的方面有希望的结果。</p><p>  An impressive example of cellular reprogramming was the   restoration of vision in blind mice with a severed optic nerve using 3 of the 4 Yamanaka factors. The researchers from Harvard Medical School were able to regrow a fully functioning optic nerve in mice using cellular reprogramming. This approach could be used in future to regenerate other tissues as a new anti-aging strategy.</p><p>  细胞重编程的一个令人印象深刻的例子是使用4种Yamanaka因子中的3种在视神经切断的盲小鼠中恢复视力。哈佛医学院的研究人员使用细胞重编程能够使小鼠的视神经再生。这种方法可在将来用作新的抗衰老策略来再生其他组织。</p><p>  Hallmarks of aging targeted: Cellular reprogramming has been shown to reverse many of the   hallmarks of aging, such as mitochondrial dysfunction, shortening of telomere length, changes in epigenetic marks, genomic instability, and cellular senescence.</p><p>  靶向衰老的标志：细胞重编程已显示出可以逆转许多衰老的标志，例如线粒体功能障碍，端粒长度缩短，表观遗传标志的变化，基因组不稳定性和细胞衰老。</p><p>   Although not covered here, there are many other promising strategies for rejuvenation including   thymic rejuvenation which has been shown to   reverse biological age in humans,   sirtuin enzyme activation with drugs such as resveratrol, and boosting mitochondrial function with   NAD+ precursor molecules. All of these show the potential to increase healthy lifespan by targeting the hallmarks of aging.</p><p>   尽管此处未涵盖，但还有许多其他充满希望的复兴策略，包括已证明可逆转人类的生物年龄，通过白藜芦醇等药物激活瑟土因酶并利用NAD +前体分子增强线粒体功能的胸腺再生。所有这些都表明，有针对性地通过老化来增加健康寿命的潜力。 </p><p>   Aging is essentially damage accumulation that occurs as a by-product of metabolism and causes the diseases that kill most people today. This damage comes in 9 forms, which are the hallmarks of aging. Many therapeutic strategies show great promise in extending healthy human lifespan by reversing the damage accumulated with aging. Four of the most promising strategies to extend lifespan in humans include parabiosis, metabolic manipulation, senolytics, and cellular reprogramming.</p><p>衰老本质上是损害积累，它是新陈代谢的副产品，会导致当今大多数人死亡的疾病。这种损坏有9种形式，这是老化的标志。许多治疗策略通过逆转随着年龄增长而累积的损害，显示出延长健康人类寿命的巨大希望。延长人类寿命的四种最有希望的策略包括共生，代谢操纵，senolytics和细胞重编程。</p><p>   For those wanting to help aging  be solved in our lifetime so we can avoid being   the last generation to die, consider taking the following actions:</p><p>   对于那些希望在我们的一生中解决衰老的人来说，这样我们就可以避免成为死掉的最后一代，请考虑采取以下行动：</p><p> Joining the   Longevity subreddit or the   Lifespan Discord server to plug in to longevity channels</p><p> 加入Longevity subreddit或Lifespan Discord服务器以插入长寿频道</p><p>  Donating to the   SENS research foundation. They fund the most neglected and high-impact research in this field as explained in   this LessWrong post.</p><p>  捐赠给SENS研究基金会。如这篇LessWrong文章所述，他们资助了该领域最被忽视和影响最大的研究。</p><p>           Any talks by Prof David Sinclair, Dr Aubrey de Grey, Prof Brian Kennedy, or Dr Nir Barzilai for anti-aging science. For personal longevity strategies, I recommend talks by Dr Rhonda Patrick, Dave Asprey and Dr Peter Attia.</p><p>           David Sinclair教授，Aubrey de Grey博士，Brian Kennedy教授或Nir Barzilai博士针对抗衰老科学进行的任何演讲。对于个人长寿策略，我建议Rhonda Patrick博士，Dave Asprey博士和Peter Attia博士进行演讲。</p><p>  As an effective altruist, I like to analyze how altruistic cause areas fare on  three different axes: importance, tractability and neglectedness. The arguments you gave for the importance of aging are compelling to me (at least from a short-term, human-focused perspective). I&#39;m less convinced that anti-aging efforts are worth it according to the other axes, and I&#39;ll explain some of my reasons here.</p><p>  作为一个有效的利他主义者，我喜欢分析利他主义如何在三个不同的轴上发挥作用：重要性，易处理性和被忽视性。您对衰老的重要性提出的论点对我很有说服力（至少从短期的，以人为本的角度而言）。我不太相信从其他角度来看抗衰老是值得的，在这里我将解释一些我的理由。</p><p> The evidence is promising that in the next 5-10 years, we will start seeing robust evidence that aging can be therapeutically slowed or reversed in humans. [...] In the lab, we have demonstrated that various anti-aging approaches can extend healthy lifespan in many model organisms including   yeast, worms, fish, flies, mice and rats. Life extension of model organisms using anti-aging approaches ranges from   30% to 1000%:</p><p> 有证据表明，在未来的5-10年中，我们将开始看到有力的证据表明，衰老可以通过治疗性方式减缓或逆转人类的生命。 daccess-ods.un.org daccess-ods.un.org在实验室中，我们已经证明了各种抗衰老方法可以延长许多模型生物的健康寿命，包括酵母，蠕虫，鱼，蝇，小鼠和大鼠。使用抗衰老方法可使模型生物的寿命延长30％至1000％： </p><p> When looking at the graph you present, a clear trend emerges: the more complex and larger the organism, the less progress we have made on slowing aging for that organism. Given that humans are much more complex and larger than the model organisms you presented, I&#39;d caution against extrapolating lab results to them.</p><p>当查看您呈现的图形时，就会出现一个明显的趋势：生物体越复杂和越大，我们在减缓该生物体衰老方面所取得的进展就越少。鉴于人类比您介绍的模型生物复杂得多，规模也更大，因此，我警告不要将实验室结果外推给他们。</p><p> I once heard from a cancer researcher that we had, for all practical purposes, cured cancer in mice, but the results have not yet translated into humans. Whether or not this claim is true, it&#39;s clear that progress has been slower than the starry-eyed optimists had expected back  in 1971.</p><p> 我曾经从一位癌症研究人员那里得知，从所有实际目的出发，我们已经治愈了小鼠的癌症，但结果尚未转化为人类。无论这一说法是否属实，很明显进展比1971年满天星斗的乐观主义者所预期的要慢。</p><p> That&#39;s not to say that there hasn&#39;t been progress in cancer research, or biological research more broadly. It&#39;s just that progress tends to happen gradually. I don&#39;t doubt that we can achieve modest success; I think it&#39;s plausible ( &gt;30% credence) that we will have FDA approved anti-aging treatments by 2030. But I&#39;m very skeptical that these modest results will trigger an anti-aging revolution that substantially affects lifespan and quality of life in the way that you have described.</p><p> 这并不是说癌症研究或生物学研究尚未取得任何进展。只是进步趋向于逐渐发生。我毫不怀疑我们可以取得适度的成功；我认为到2030年我们将获得FDA批准的抗衰老治疗似乎是有道理的（> 30％的可信度）。但是我非常怀疑这些适度的结果是否会引发实质性影响的抗衰老革命您所描述的寿命和生活质量。</p><p> Most generally, scientific fields  tend to have diminishing marginal returns, since all the low-hanging fruit tends to get plucked early on. In the field of anti-aging, even the lowest hanging fruit (ie. the treatments you described) don&#39;t seem very promising. At best, they might deliver an impact roughly equivalent to adding a decade or two of healthy life. At that level, human life would be meaningfully affected, but the millennia-old cycle of birth-to-death would remain almost unchanged.</p><p> 一般而言，科学领域的边际收益往往会减少，因为所有悬而未决的成果往往会在早期被采摘。在抗衰老领域，即使是挂得最低的水果（即您所描述的治疗方法）似乎也没有什么希望。充其量，它们所产生的影响可能大致相当于增加十年或两年的健康生活。在这个水平上，人类的生活将受到有意义的影响，但几千年来从出生到死亡的周期将几乎保持不变。</p><p>  From the perspective of altruistic neglectedness, this fact counts against anti-aging as a promising field to go into. The fact that there are 130 companies working on the problem with only minor laboratory success in the last decade indicates that the marginal returns to new inputs is low. One more researcher, or one more research grant will add little to the rate of progress.</p><p>  从无私的忽视的角度来看，这一事实将抗衰老视为一个有前途的领域。在过去的十年中，有130家公司致力于解决这个问题，但在实验室中仅取得了很小的成功，这表明新投入的边际回报很低。再增加一名研究人员，或再增加一项研究补助金，将不会增加进步的速度。</p><p> In my opinion, if robust anti-aging technologies do exist in say, 50 years, the most likely reason would be that overall technological progress sped up dramatically (for example, due to  transformative AI), and progress in anti-aging was merely a side effect of this wave of progress.</p><p> 我认为，如果说在50年内确实存在强大的抗衰老技术，则最可能的原因是整体技术进步急剧加快（例如，由于变革性的AI），而抗衰老的进展仅仅是这波进步的副作用。</p><p> It&#39;s also possible that anti-aging science is a different kind of science than most fields, and we have reason to expect a discontinuity in progress some time soon (for one potential argument, see the last several paragraphs of  my post here). The problem is that this argument is vunerable to the standard reply usually given against arguments for technological discontinuities: they&#39;re rare.</p><p> 抗衰老科学也有可能是与大多数领域不同的一类科学，我们有理由期待不久的将来会出现不连续性（有关一个潜在的论点，请参见此处的最后几段） ）。问题在于，这种论点对通常针对技术不连续性论点的标准回答很不利：它们很少见。 </p><p> (However I do recommend reading some material investigating the frequency of technological discontinuities  here. Maybe you can find some similarities with past technological discontinuities? :) )</p><p>（但是，我建议您在此处阅读一些调查技术不连续性频率的材料。也许您会发现与过去的技术不连续性有相似之处？:)）</p><p> I am also an effective altruist and have been involved in the movement since 2012. I and others think that anti-aging and donating to SENS is probably a more important cause area than most EA cause areas (especially short-term ones) besides X-risk for the reasons below.   As a side note, from the longer (200+ comment) discussion about anti-aging from an EA perspective on the  EA Facebook group here, the main objection that held weight seemed to be &#39;bang for buck&#39;, and is also addressed below.   In this piece:  Why SENS Makes Sense and this piece:  A general framework for evaluating aging research. Part 1: reasoning with Longevity Escape Velocity Emanuale Ascani evaluates the cost effectiveness of anti-aging, and donations to SENS Research Foundation using the EA criteria of scale, neglectedness and tractability. His estimation of cost-effectiveness of a SENS donation is  $2.50 per 1000 quality-adjusted years life years saved, which dwarfs most other short-term cause areas in EA.</p><p> 我也是一位有效的利他主义者，自2012年以来一直参与这项运动。我和其他人认为，抗衰老和向SENS捐款可能是比大多数EA原因（尤其是短期原因）更为重要的原因领域，除了X-出于以下原因有风险。附带说明一下，从EA Facebook小组从EA角度进行的有关抗衰老的较长讨论（超过200条评论）中，保持体重的主要反对意见似乎是“讨价还价”，以及也在下面解决。在本文中：SENS为何有意义；在本文中：评价老化研究的通用框架。第1部分：使用长寿逃生速度进行推理Emanuale Ascani评估抗衰老的成本效益，并使用EA的规模，被忽视和易处理性标准来向SENS Research Foundation捐款。他估计SENS捐赠的成本效益是每保存1000个质量调整的生命年可节省2.50美元，这使EA中的其他大多数短期原因相形见war。</p><p> In terms of tractability and neglectedness, I&#39;ll add a few more thoughts:  (1) Tractability  I understand that considering the models of aging (mice, flies, yeast etc.) alone might give the impression that these therapies may not translate to humans. However:  Human trials for aging specifically for three of the four approaches I mentioned are currently underway, but the lack of human data for these approaches ought not to undermine the scientific feasibility of, given results of other trials in humans. Data from human tria</p><p> 关于易处理性和忽略性，我将添加一些其他想法：（1）可牵引性我了解仅考虑衰老模型（小鼠，苍蝇，酵母等）可能给人的印象是这些疗法可能无法转化对人类。但是，目前正在针对我提到的四种方法中的三种方法进行针对衰老的人体试验，但是考虑到其他人体试验的结果，缺乏针对这些方法的人体数据不应损害其科学可行性。来自人类的数据</p><p>......</p><p>...... </p></div><div id="story_share_this"><div class="sharethis-inline-share-buttons"></div></div><div class="text-break sotry_link page_narrow"><a target="_blank" href="https://www.lesswrong.com/posts/RcifQCKkRc9XTjxC2/anti-aging-state-of-the-art">https://www.lesswrong.com/posts/RcifQCKkRc9XTjxC2/anti-aging-state-of-the-art</a></div><div class="story_tags page_narrow"><button type="button" class="btn btn-light my_tag"><a href="/tag/抗衰老/">#抗衰老</a></button><button type="button" class="btn btn-light my_tag"><a href="/tag/aging/">#aging</a></button></div></div><div class="my_movie_list_item shadow p-3 mb-5 bg-white rounded"><button type="button" class="btn btn-link my_tag"><a href="/tag/web2.0/">#web2.0</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/google/">#google</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/设计/">#设计</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/创意/">#创意</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/摄影/">#摄影</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/游戏/">#游戏</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/图片/">#图片</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/软件/">#软件</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/视频/">#视频</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/手机/">#手机</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/广告/">#广告</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/iphone/">#iphone</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/网站/">#网站</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/免费/">#免费</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/windows/">#windows</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/下载/">#下载</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/苹果/">#苹果</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/微软/">#微软</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/apple/">#apple</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/firefox/">#firefox</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/blog/">#blog</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/音乐/">#音乐</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/博客/">#博客</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/wordpress/">#wordpress</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/恶搞/">#恶搞</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/qq/">#qq</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/艺术/">#艺术</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/web/">#web</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/工具/">#工具</a></button><button type="button" class="btn btn-link my_tag"><a href="/tag/分享/">#分享</a></button></div></div></div><div id="my_footer"><div class=""><a href="/tags/">tags</a> <a href="/users/">users</a></div>&copy; 2020 diglog.com </div></div></body></html>